Clinical Trial

A Phase 2a Study to Evaluate the Safety, Tolerability, and Efficacy of SNP318 in DME Patients

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The objective of this study is to assess the safety, efficacy, and tolerability of SNP318 in patients with DME.
Trial Details
NCT Number NCT07199777
Lead Sponsor SciNeuro
Conditions Diabetic Macular Edema, DME
Enrollment 60 participants
Start Date 2025-11
Primary Completion 2026-11 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2025-09-30